These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Preliminary results in invasive bladder cancer with transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy. Prout GR; Shipley WU; Kaufman DS; Heney NM; Griffin PP; Althausen AF; Bassil B; Nocks BN; Parkhurst EC; Young HH J Urol; 1990 Nov; 144(5):1128-34; discussion 1134-6. PubMed ID: 2122007 [TBL] [Abstract][Full Text] [Related]
31. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer. Milowsky MI; Stadler WM; Bajorin DF BJU Int; 2008 Nov; 102(9 Pt B):1339-44. PubMed ID: 19035902 [TBL] [Abstract][Full Text] [Related]
32. Upstaging of nonurothelial histology in bladder cancer at the time of surgical treatment in the National Cancer Data Base. Cohen AJ; Packiam V; Nottingham C; Steinberg G; Smith ND; Patel S Urol Oncol; 2017 Jan; 35(1):34.e1-34.e8. PubMed ID: 27592529 [TBL] [Abstract][Full Text] [Related]
33. RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy. Hagan MP; Winter KA; Kaufman DS; Wajsman Z; Zietman AL; Heney NM; Toonkel LM; Jones CU; Roberts JD; Shipley WU Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):665-72. PubMed ID: 14529770 [TBL] [Abstract][Full Text] [Related]
34. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors. Angulo JC; Sanchez-Chapado M; Lopez JI; Flores N J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282 [TBL] [Abstract][Full Text] [Related]
35. A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer. Scher HI J Urol; 1994 Aug; 152(2 Pt 1):574-5. PubMed ID: 8015114 [No Abstract] [Full Text] [Related]
36. Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study. Fellin G; Graffer U; Bolner A; Ambrosini G; Caffo O; Luciani L Br J Urol; 1997 Jul; 80(1):44-9. PubMed ID: 9240179 [TBL] [Abstract][Full Text] [Related]
37. Treatment of Small Cell Carcinoma of the Bladder With Chemotherapy and Radiation after Transurethral Resection of a Bladder Tumor. Bryant CM; Dang LH; Stechmiller BK; Gilbert SM; Morris CG; Zlotecki RA Am J Clin Oncol; 2016 Feb; 39(1):69-75. PubMed ID: 24517956 [TBL] [Abstract][Full Text] [Related]
38. [Chemotherapy in the treatment of advanced urothelial tumors]. Sternberg CN Urologe A; 1991 Jan; 30(1):33-44. PubMed ID: 2014585 [TBL] [Abstract][Full Text] [Related]
40. The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group. Splinter TA; Scher HI; Denis L; Bukowski R; Simon S; Klimberg I; Soloway M; Vogelzang NJ; van Tinteren H; Herr H J Urol; 1992 Mar; 147(3):606-8. PubMed ID: 1538438 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]